Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Journal of Molecular Medicine
In physiciansupervised settings, BPC157 and TB500 have shown favorable safety profiles in preclinical and early clinical use, with most side effects being mild and transient (such as temporary injectionsite irritation or mild digestive changes)
Dutasteride is stronger but has a different safety profile and is often used off-label
Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
Metformin and Vitamin B12: A
US$ 24.43
US$ 28.74
US$ 26.81
US$ 29.89
US$ 21.25
US$ 22.10
US$ 25.80
US$ 25.48